HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pablo Gajate Selected Research

DNA (Deoxyribonucleic Acid)

11/2021Sunitinib and Evofosfamide (TH-302) in Systemic Treatment-Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE-1408 Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pablo Gajate Research Topics

Disease

17Neoplasms (Cancer)
05/2023 - 01/2018
6Carcinoma (Carcinomatosis)
05/2023 - 01/2018
6Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2021 - 01/2017
3Fatigue
10/2021 - 10/2019
3Disease Progression
10/2021 - 01/2020
3Primitive Neuroectodermal Tumors (PNET)
01/2020 - 01/2017
1Bronchiolitis Obliterans Syndrome
05/2023
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2023
1Kidney Neoplasms (Kidney Cancer)
01/2023
1Stomach Neoplasms (Stomach Cancer)
10/2022
1Prostatic Neoplasms (Prostate Cancer)
02/2022
1medullary Thyroid cancer
01/2022
1Delayed Hypersensitivity (Hypersensitivity, Type IV)
01/2022
1Encephalitis (Encephalitis, Rasmussen)
01/2022
1Peripheral Nervous System Diseases (PNS Diseases)
01/2022
1COVID-19
01/2022
1Hypoxia (Hypoxemia)
11/2021
1Hypertension (High Blood Pressure)
10/2021
1Diarrhea
10/2021
1Lung Neoplasms (Lung Cancer)
01/2021
1Brain Neoplasms (Brain Tumor)
01/2021
1Nausea
01/2021
1Neoplasm Metastasis (Metastasis)
01/2021
1Pneumonia (Pneumonitis)
01/2021
1Neuroendocrine Carcinoma
01/2021
1Melanoma (Melanoma, Malignant)
10/2020
1Renal Cell Carcinoma (Grawitz Tumor)
10/2020
1Necrosis
10/2020
1Insulinoma
11/2019
1Hypoglycemia (Reactive Hypoglycemia)
11/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2019
1Squamous Cell Carcinoma of Head and Neck
10/2019
1Squamous Cell Neoplasms (Squamous Cell Cancer)
10/2019
1Ovarian Neoplasms (Ovarian Cancer)
01/2019
1Colorectal Neoplasms (Colorectal Cancer)
12/2012

Drug/Important Bio-Agent (IBA)

3NivolumabIBA
02/2023 - 10/2020
3Monoclonal AntibodiesIBA
10/2022 - 12/2012
2Tyrosine Kinase InhibitorsIBA
10/2022 - 01/2021
2PlatinumIBA
10/2022 - 01/2019
1Agammaglobulinaemia Tyrosine KinaseIBA
05/2023
1ibrutinibIBA
05/2023
1Cisplatin (Platino)FDA LinkGeneric
01/2023
1Radioisotopes (Radionuclides)IBA
01/2023
1Peptide Receptors (Peptide Receptor)IBA
01/2023
1Immunoconjugates (Immunoconjugate)IBA
10/2022
1Chimeric Antigen ReceptorsIBA
02/2022
1Immune Checkpoint InhibitorsIBA
02/2022
1atezolizumabIBA
01/2022
1TabletsIBA
01/2022
1cabozantinibIBA
01/2022
1VaccinesIBA
01/2022
1Complement System Proteins (Complement)IBA
01/2022
1Capsules (Microcapsules)IBA
01/2022
1mRNA VaccinesIBA
01/2022
1ProdrugsIBA
11/2021
1isophosphamide mustard (IPAM)IBA
11/2021
1TH 302IBA
11/2021
1Sunitinib (Sutent)FDA Link
11/2021
1Alkylating AgentsIBA
11/2021
1DNA (Deoxyribonucleic Acid)IBA
11/2021
1Angiogenesis InhibitorsIBA
11/2021
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
10/2021
1lenvatinibIBA
10/2021
1Aspartic Acid (Aspartate)FDA Link
01/2021
1Transaminases (Aminotransferases)IBA
01/2021
1Alanine (L-Alanine)FDA Link
01/2021
1B7-H1 AntigenIBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1spartalizumabIBA
01/2021
1osimertinibIBA
01/2021
1pembrolizumabIBA
10/2020
1BO-112IBA
10/2020
1Poly I-CIBA
10/2020
1palbociclibIBA
01/2020
1LutetiumIBA
11/2019
1lutetium Lu 177 dotatateIBA
11/2019
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
11/2019
1RogaratinibIBA
10/2019
1Messenger RNA (mRNA)IBA
10/2019
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
10/2019
1Lipase (Acid Lipase)FDA Link
10/2019
1TrabectedinIBA
01/2019
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2018
1Fluorouracil (Carac)FDA LinkGeneric
01/2018
1Temozolomide (Temodar)FDA LinkGeneric
03/2017
1Capecitabine (Xeloda)FDA Link
03/2017
1EverolimusFDA Link
01/2017
1ErbB Receptors (EGF Receptor)IBA
12/2012
1Cetuximab (Erbitux)FDA Link
12/2012
1Codon (Codons)IBA
12/2012

Therapy/Procedure

8Therapeutics
05/2023 - 10/2021
3Drug Therapy (Chemotherapy)
10/2022 - 03/2017
3Immunotherapy
10/2022 - 01/2022
2Cystectomy
01/2023 - 01/2023
2Radiotherapy
01/2023 - 01/2021
1Neoadjuvant Therapy
01/2023
1Nephroureterectomy
01/2023
1Castration
02/2022
1Drug Tapering
10/2021
1Aftercare (After-Treatment)
10/2021